BACKGROUND: Measurement of biomarkers has been incorporated within clinical research
studies of asthma to characterize the population and associate the disease with
environmental and therapeutic effects. OBJECTIVE: National Institutes of Health institutes
and federal agencies convened an expert group to propose which biomarkers should be
assessed as standardized asthma outcomes in future clinical research studies. METHODS:
We conducted a comprehensive search of the literature to identify studies that developed …